Production (Stage)
Jolt Health Inc.
JTHTF
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 457.85% | -67.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 457.85% | -67.52% | |||
| Operating Income | -457.85% | 67.52% | |||
| Income Before Tax | -856.30% | 66.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -856.30% | 66.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -856.30% | 66.58% | |||
| EBIT | -457.85% | 67.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -853.75% | 66.53% | |||
| Normalized Basic EPS | -460.00% | 66.44% | |||
| EPS Diluted | -853.75% | 66.53% | |||
| Normalized Diluted EPS | -460.00% | 66.44% | |||
| Average Basic Shares Outstanding | 0.06% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||